Form: 5/A

Annual statement of changes in beneficial ownership of securities

March 9, 2001

5/A: Annual statement of changes in beneficial ownership of securities

Published on March 9, 2001




------------------------------
OMB APPROVAL
------------------------------
OMB Number
Expires:
Estimated average burden
hours per response ....... 1.0
------------------------------


U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 5

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940

[_] Check box if no longer subject to Section 16. Form 4 or Form 5 obligations
may continue. See Instruction 1(b).

[x] Form 3 Holdings Reported

[x] Form 4 Transactions Reported

________________________________________________________________________________
1. Name and Address of Reporting Person*

McNamara Donald J.
- --------------------------------------------------------------------------------
(Last) (First) (Middle)

4200 Texas Commerce Tower West,
2200 Ross Avenue
- --------------------------------------------------------------------------------
(Street)

Dallas TX 75201
- --------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol

Omega Healthcare Investors, Inc. (OHI)
________________________________________________________________________________
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)



________________________________________________________________________________
4. Statement for Month/Year


12/00
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Year)



________________________________________________________________________________
6. Relationship of Reporting Person to Issuer
(Check all applicable)

[X] Director [X] 10% Owner
[ ] Officer (give title below) [_] Other (specify below)


______________________________________________________________________________
7. Individual or Joint/Group Filing
(Check applicable line)

[x] Form filed by one Reporting Person
[_] Form filed by more than one Reporting Person
________________________________________________________________________________


================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================



5. 6.
4. Amount of Owner-
Securities Acquired (A) or Securities ship
Disposed of (D) Beneficially Form: 7.
(Instr. 3, 4 and 5) Owned at End Direct Nature of
2. 3. ----------------------------- of Issuer's (D) or Indirect
1. Transaction Transaction (A) Fiscal Year Indirect Beneficial
Title of Security Date Code Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (mm/dd/yy) (Instr. 8) (D) and 4) (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------


No securities owned
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================

* If the form is filed by more than one Reporting Person, see Instruction
4(b)(v).

Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.


(Over)
(Form 5-07/98)



FORM 5 (continued)

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

================================================================================


9. 10.
Number Owner-
of ship
2. Deriv- of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- Securities Date Securities Price Bene- ity: In-
cise 3. Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- 4. or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Trans- of (D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date action (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ Code 4 and 5) Date Expira- Number ity Year (I) ship
Security Secur- Day/ (Instr. ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) 8) (A) (D) cisable Date Title Shares 5) 4) 4) 4)
- ------------------------------------------------------------------------------------------------------------------------------------

Options
(right to buy) $6.25 10/17/00 A3** A 3,333 on 7/17/11 Common 10,000 $6.25 10,000 D
10/17/01; Stock
3,333 on
10/17/02;
3,334 on
10/17/03
- ------------------------------------------------------------------------------------------------------------------------------------
Options
(right to buy) $3.8125 01/01/01 A4 A 333 on 1/1/12 Common 1,000 $3.8125 11,000 D
01/01/02; Stock
333 on
01/01/03;
334 on
01/01/04
- ------------------------------------------------------------------------------------------------------------------------------------
Series C $6.25 07/17/00 A3 A 07/17/00 n/a Common 16,000,000 $100.00 1,000,000 D
Preferred Stock Stock
***
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================

Explanation of Responses:
** - Mr. McNamara was granted 10,000 options upon the effective date of his
appointment to the Board of Directors.

*** - Mr. McNamara disclaims beneficial ownership of the Series C Preferred
Stock, which he is deemed beneficial owner because of his membership interest
in The Hampstead Group, L.L.C, which holds the ultimate controlling interest in
Explorer Holdings, L.P.





/s/ Donald J. McNamara February 14, 2001
- --------------------------------------------- -----------------------
**Signature of Reporting Person Date

** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.

See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.


Page 2